
|Videos|August 11, 2022
Exciting Emerging Data in Prostate Cancer
Author(s)Stephen J. Freedland, MD
Stephen J. Freedland, MD, highlights emerging data to look out for that might address unmet needs in prostate cancer testing and treatment.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves enfortumab vedotin plus pembrolizumab for MIBC
2
Amy E. Krambeck, MD, on choosing between CVAC and FANS for suction-based ureteroscopy
3
Urocross shows sustained benefit through 24 months post-removal
4
Study suggests tamsulosin deprescribing may be appropriate for select men with BPH
5














